2021 - IHE

Hofmarcher T, Keel G, Lindgren P Cancer care and access to cancer drugs in Asia-Pacific – Main report IHE Report 2021:3, IHE: Lund, Sweden
Hofmarcher T, Keel G, Lindgren P Pricing policies for off-patent drugs in Asia-Pacific IHE Report 2021:3g, IHE: Lund, Sweden
Hofmarcher T, Keel G, Lindgren P Health spending on cancer drugs and unmet patient needs in Asia-Pacific IHE Report 2021:3f, IHE: Lund, Sweden
Hofmarcher T, Keel G, Lindgren P Patient access to innovative cancer drugs in Asia-Pacific IHE Report 2021:3e, IHE: Lund, Sweden
Andersson E, Lindgren P, Brådvik G, Ramdén V, Steen Carlsson K Kostnader för hjärt-kärlsjukdom i Sverige 2019 IHE Rapport 2021:4, IHE, Lund, Sverige
Olsson P, Skröder C, Ahlbeck L, Hjalte F, Welin K-O, Westin U, Andersson M, Ahlström-Emanuelsson C, Cardell L-O HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study Allergy, Asthma & Clinical Immunology 17, 55 (2021)
DOI: https://doi.org/10.1186/s13223-021-00560-3
Hofmarcher T, Keel G, Lindgren P Health spending on cancer in Asia-Pacific IHE Report 2021:3d, IHE: Lund, Sweden
Hofmarcher T, Keel G, Lindgren P The burden of cancer in Asia-Pacific IHE Report 2021:3c, IHE: Lund, Sweden
Hofmarcher T, Keel G, Lindgren P Cancer care and access to cancer drugs in Asia-Pacific – Executive summary IHE Report 2021:3b, IHE: Lund, Sweden
Hofmarcher T, Keel G, Lindgren P Cancer care and access to cancer drugs in Asia-Pacific ‒ Introduction IHE Report 2021:3a, IHE: Lund, Sweden

Nästa »